Clinical Trial Update: A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children With Cystic Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Nutropin AQ for growth restriction in children with cystic fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Nutropin AQ (somatropin)

Snippet

Sponsor: Genentech, Inc. | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED